Lipid-based nanoformulations for peptide delivery

International Journal of Pharmaceutics

Volumn 502, Issue 1-2, 2016, Pages 80-97

  Matougui, Nada ^a,d   Boge, Lukas ^b   Groo, Anne Claire ^a   Umerska, Anita ^a   Ringstad, Lovisa ^b   Bysell, Helena ^b   Saulnier, Patrick ^a,c  

^a UNIVERSITÉ D'ANGERS   (France)

^b SP TECHNICAL RESEARCH INSTITUTE OF SWEDEN   (Sweden)

^c ANGERS UNIVERSITY HOSPITAL   (France)

^d INSERM   (France)

Author keywords

Drug delivery; Lipids; Nanoformulations; Peptides

Indexed keywords

DRUG CARRIER; LIPID; LIPID NANOCAPSULE; LIPOSOME; LIQUID CRYSTALLINE NANOPARTICLE; NANOPARTICLE; NANOSTRUCTURED LIPID CARRIER; PEPTIDE DERIVATIVE; PHOSPHOLIPID; SOLID LIPID NANOPARTICLE; UNCLASSIFIED DRUG; PEPTIDE;

HUMAN; LIPOSOMAL DELIVERY; MICELLE; NANOEMULSION; NANOFABRICATION; NANOPHARMACEUTICS; PRIORITY JOURNAL; REVIEW; ANIMAL; CHEMISTRY; MEDICINAL CHEMISTRY;

ANIMALS; CHEMISTRY, PHARMACEUTICAL; DRUG CARRIERS; HUMANS; LIPIDS; NANOPARTICLES; PEPTIDES;

EID: 84959179307     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2016.02.019     Document Type: Review

References (226)

1. A. Çilek, N. Çelebi, F. Tirnaksiz, and A. Tay A lecithin-based microemulsion of rh-insulin with aprotinin for oral administration: investigation of hypoglycemic effects in non-diabetic and STZ-induced diabetic rats Int. J. Pharm. 298 2005 176 185
2. H. Önyüksel, F. Séjourné, H. Suzuki, and I. Rubinstein Human VIP-α A long-acting, biocompatible and biodegradable peptide nanomedicine for essential hypertension Peptides 27 2006 2271 2275
3. H. Önyüksel, P.S. Mohanty, and I. Rubinstein VIP-grafted sterically stabilized phospholipid nanomicellar 17-allylamino-17-demethoxy geldanamycin: a novel targeted nanomedicine for breast cancer Int. J. Pharm. 365 2009 157 161
4. I. Ahmad, M. Longenecker, J. Samuel, and T.M. Allen Antibody-targeted delivery of doxorubicin entrapped in sterically stabilized liposomes can eradicate lung cancer in mice Cancer Res. 53 1993 1484 1488
5. A.J. Almeida, and E. Souto Solid lipid nanoparticles as a drug delivery system for peptides and proteins Adv. Drug Deliv. Rev. 59 2007 478 490
6. A.J. Almeida, S. Runge, and R.H. Müller Peptide-loaded solid lipid nanoparticles (SLN): Influence of production parameters Int. J. Pharm. 149 1997 255 265
7. M.P. Alves, A.L. Scarrone, M. Santos, A.R. Pohlmann, and S.S. Guterres Human skin penetration and distribution of nimesulide from hydrophilic gels containing nanocarriers Int. J. Pharm. 341 2007 215 220
8. C.R. Alving, E.A. Steck, W.L. Chapman, V.B. Waits, L.D. Hendricks, G.M. Swartz, and W.L. Hanson Therapy of leishmaniasis: superior efficacies of liposome-encapsulated drugs Proc. Natl. Acad. Sci. U. S. A 75 1978 2959 2963
9. Anton N., Saulnier P., Benoit J.P., 2009. Aqueous-core lipid nanocapsules for encapsulating hydrophilic and/or lipophilic molecules. WO2009037310 2009 A2.
10. N. Anton, H. Mojzisova, E. Porcher, J.P. Benoit, and P. Saulnier Reverse micelle-loaded lipid nano-emulsions: new technology for nano-encapsulation of hydrophilic materials Int. J. Pharm. 398 2010 204 209
11. B. Ashok, L. Arleth, R.P. Hjelm, I. Rubinstein, and H. Önyüksel In vitro characterization of PEGylated phospholipid micelles for improved drug solubilization: effects of PEG chain length and PC incorporation J. Pharm. Sci. 93 2004 2476 2487
12. A. Béduneau, F. Hindré, A. Clavreul, J.C. Leroux, P. Saulnier, and J.P. Benoit Brain targeting using novel lipid nanovectors J. Control. Release 126 2008 44 49
13. A. Badiee, M.R. Jaafari, and A. Khamesipour Leishmania major: immune response in BALB/c mice immunized with stress-inducible protein 1 encapsulated in liposomes Exp. Parasitol. 115 2007 127 134
14. A. Banerjee, and H. Onyuksel Peptide delivery using phospholipid micelles Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 4 2012 562 574
15. A.D. Bangham, M.M. Standish, and J.C. Watkins Diffusion of univalent ions across the lamellae of swollen phospholipids J. Mol. Biol. 13 1965 238 252
16. J. Barauskas, and T. Landh Phase behavior of the phytantriol/water system Langmuir 19 2003 9562 9565
17. J. Barauskas, M. Johnsson, F. Joabsson, and F. Tiberg Cubic phase nanoparticles (cubosome): Principles for controlling size, structure, and stability Langmuir 21 2005 2569 2577
18. J. Barauskas, C. Cervin, M. Jankunec, M. Špandyreva, K. Ribokaite, F. Tiberg, and M. Johnsson Interactions of lipid-based liquid crystalline nanoparticles with model and cell membranes Int. J. Pharm. 391 2010 284 291
19. P. Blasi, A. Schoubben, G. Traina, G. Manfroni, L. Barberini, P.F. Alberti, C. Cirotto, and M. Ricci Lipid nanoparticles for brain targeting III: long-term stability and in vivo toxicity Int. J. Pharm. 454 2013 316 323
20. B.J. Boyd, D.V. Whittaker, S.-M. Khoo, and G. Davey Lyotropic liquid crystalline phases formed from glycerate surfactants as sustained release drug delivery systems Int. J. Pharm. 309 2006 218 226
21. B.J. Boyd, D.V. Whittaker, S.M. Khoo, and G. Davey Hexosomes formed from glycerate surfactants-Formulation as a colloidal carrier for irinotecan Int. J. Pharm. 318 2006 154 162
22. B.J. Boyd Characterisation of drug release from cubosomes using the pressure ultrafiltration method Int. J. Pharm. 260 2003 239 247
23. K. Brandenburg, I. Rubinstein, R. Sadikot, and H. Önyüksel Polymyxin B self-associated with phospholipid nanomicelles Pharm. Dev. Technol. 17 2012 654 660
24. C. Chen, T. Fan, Y. Jin, Z. Zhou, Y. Yang, X. Zhu, Z. Zhang, Q. Zhang, and Y. Huang Orally delivered salmon calcitonin-loaded solid lipid nanoparticles prepared by micelle-double emulsion method via the combined use of different solid lipids Nanomedicine 8 2013 1085 1100
25. L. Cao Immobilised enzymes: science or art? Curr. Opin. Chem. Biol. 9 2005 217 226
26. C. Cervin, P. Vandoolaeghe, C. Nistor, F. Tiberg, and M. Johnsson A combined in vitro and in vivo study on the interactions between somatostatin and lipid-based liquid crystalline drug carriers and bilayers Eur. J. Pharm. Sci. 36 2009 377 385
27. H. Cesur, I. Rubinstein, A. Pai, and H. Önyüksel Self-associated indisulam in phospholipid-based nanomicelles: a potential nanomedicine for cancer Nanomedicine 5 2009 178 183
28. G. Cevc Lipid vesicles and other colloids as drug carriers on the skin Adv. Drug Deliv. Rev. 56 2004 675 711
29. Yulin Chen, Ping Ma, and S. Gui Cubic and hexagonal liquid crystals as drug delivery systems Biomed. Res. Int. 2014 815981
30. J.Y.T. Chong, X. Mulet, L.J. Waddington, B.J. Boyd, and C.J. Drummond High-throughput discovery of novel steric stabilizers for cubic lyotropic liquid crystal nanoparticle dispersions Langmuir 28 2012 9223 9232
31. J.Y.T. Chong, X. Mulet, D.J. Keddie, L. Waddington, S.T. Mudie, B.J. Boyd, and C.J. Drummond Novel steric stabilizers for lyotropic liquid crystalline nanoparticles: PEGylated-Phytanyl copolymers Langmuir 31 2015 2615 2629
32. S. Chono, R. Fukuchi, T. Seki, and K. Morimoto Aerosolized liposomes with dipalmitoyl phosphatidylcholine enhance pulmonary insulin delivery J. Control. Release 137 2009 104 109
33. H. Chung, J. Kim, J.Y. Um, I.C. Kwon, and S.Y. Jeong Self-assembled nanocubicle as a carrier for peroral insulin delivery Diabetologia 45 2002 448 451
34. L.C. Collins-Gold, R.T. Lyons, and L.C. Bartholow Parenteral emulsions for drug delivery Adv. Drug Deliv. Rev. 5 1990 189 208
35. M.J. Copland, T. Rades, N.M. Davies, and M.A. Baird Lipid based particulate formulations for the delivery of antigen Immunol. Cell Biol. 83 2005 97 105
36. R. Cortesi, E. Esposito, G. Luca, and C. Nastruzzi Production of lipospheres as carriers for bioactive compounds Biomaterials 23 2002 2283 2294
37. S. Dagar, H. Önyüksel, S. Akhter, A. Krishnadas, and I. Rubinstein Human galanin expresses amphipathic properties that modulate its vasoreactivity in vivo Peptides 24 2003 1373 1380
38. C. Dai, B. Wang, H. Zhao, and B. Li Factors affecting protein release from microcapsule prepared by liposome in alginate Colloids Surf. B Biointerfaces 42 2005 253 258
39. C. Dai, B. Wang, H. Zhao, B. Li, and J. Wang Preparation and characterization of liposomes-in-alginate (LIA) for protein delivery system Colloids Surf. B. Biointerfaces 47 2006 205 210
40. S. Das, and A. Chaudhury Recent advances in lipid nanoparticle formulations with solid matrix for oral drug delivery AAPS PharmSciTech 12 2011 62 76
41. P.F. Dimond Could stapling revive peptide therapeutics? Genet. Eng. Biotechnol. News 2010
42. S.T. Dogru, S. Çalis, and F. Öner Oral multiple w/o/w emulsion formulation of a peptide salmon calcitonin: in vitro-in vivo evaluation J. Clin. Pharm. Ther. 25 2000 435 443
43. E. Esposito, R. Cortesi, M. Drechsler, L. Paccamiccio, P. Mariani, C. Contado, E. Stellin, E. Menegatti, F. Bonina, and C. Puglia Cubosome dispersions as delivery systems for percutaneous administration of indomethacin Pharm. Res. 22 2005 2163 2173
44. D. Fischer, Y. Li, B. Ahlemeyer, J. Krieglstein, and T. Kissel In vitro cytotoxicity testing of polycations: influence of polymer structure on cell viability and hemolysis Biomaterials 24 2003 1121 1131
45. S.J. Fraser, X. Mulet, A. Hawley, F. Separovic, and A. Polyzos Controlling nanostructure and lattice parameter of the inverse bicontinuous cubic phases in functionalised phytantriol dispersions J. Colloid Interface Sci. 408 2013 117 124
46. R. Frkanec, D. Travas, M. Krstanovic, B. Spoljar, D. Ljevakovic, B. Vranesic, L. Frkanec, and J. Tomasic Entrapment of peptidoglycans and adamantyltripeptides into liposomes: an HPLC assay for determination of encapsulation efficiency J. Liposome Res. 13 2003 279 294
47. G. Gainza, M. Pastor, J.J. Aguirre, S. Villullas, J.L. Pedraz, R.M. Hernandez, and M. Igartua A novel strategy for the treatment of chronic wounds based on the topical administration of rhEGF-loaded lipid nanoparticles: in vitro bioactivity and in vivo effectiveness in healing-impaired db/db mice J. Control. Release 185 2014 51 61
48. M. Gallarate, M. Trotta, L. Battaglia, and D. Chirio Preparation of solid lipid nanoparticles from W/O/W emulsions: preliminary studies on insulin encapsulation J. Microencapsul. 26 2009 394 402
49. M. Gallarate, L. Battaglia, E. Peira, and M. Trotta Peptide-Loaded solid lipid nanoparticles prepared through coacervation technique Int. J. Chem. Eng. 2011 6
50. J. Gante Peptidomimetics - tailored enzyme inhibitors Angew. Chem. Int. Ed. Engl. 33 1994 1699 1720
51. M.A. García-Santana, J. Duconge, M.E. Sarmiento, M.E. Lanio-Ruíz, M.A. Becquer, L. Izquierdo, and A. Acosta-Domínguez Biodistribution of liposome-entrapped human gamma-globulin Biopharm. Drug Dispos. 27 2006 275 283
52. M. Garcia-Fuentes, D. Torres, and M.J. Alonso Design of lipid nanoparticles for the oral delivery of hydrophilic macromolecules Colloids Surf. B Biointerfaces 27 2003 159 168
53. M. Garcia-Fuentes, C. Prego, D. Torres, and M.J. Alonso A comparative study of the potential of solid triglyceride nanostructures coated with chitosan or poly(ethylene glycol) as carriers for oral calcitonin delivery Eur. J. Pharm. Sci. 25 2005 133 143
54. M. Garcia-Fuentes, D. Torres, and M.J. Alonso New surface-modified lipid nanoparticles as delivery vehicles for salmon calcitonin Int. J. Pharm. 296 2005 122 132
55. E. Garcion, A. Lamprecht, B. Heurtault, A. Paillard, A. Aubert-Pouessel, B. Denizot, P. Menei, and J.-P. Benoît A new generation of anticancer drug-loaded, colloidal vectors reverses multidrug resistance in glioma and reduces tumor progression in rats Mol. Cancer Ther. 5 2006 1710 1722
56. Gasco, M.R., 1993. Method for producing solid lipid microspheres having a narrow size distribution US5250236 A 1993.
57. L. Gentilucci, R. De Marco, and L. Cerisoli Chemical modifications designed to improve peptide stability: incorporation of non-natural amino acids pseudo-peptide bonds, and cyclization Curr. Pharm. Des. 16 2010 3185 3203
58. C.M. Goodman, C.D. McCusker, T. Yilmaz, and V.M. Rotello Toxicity of gold nanoparticles functionalized with cationic and anionic side chains Bioconjug. Chem. 15 2004 897 900
59. S. Gordon, K. Young, R. Wilson, S. Rizwan, R. Kemp, T. Rades, and S. Hook Chitosan hydrogels containing liposomes and cubosomes as particulate sustained release vaccine delivery systems J. Liposome Res. 22 2012 193 204
60. T. Goto, M. Morishita, K. Nishimura, M. Nakanishi, A. Kato, J. Ehara, and K. Takayama Novel mucosal insulin delivery systems based on fusogenic liposomes Pharm. Res. 23 2006 384 391
61. G. Gregoriadis, H. Weereratne, H. Blair, and G. Bull Liposomes in Gaucher type I disease: use in enzyme therapy and the creation of an animal model Prog. Clin. Biol. Res. 95 1982 681 701
62. G. Gregoriadis Genetic vaccines: strategies for optimization Pharm. Res. 15 1998 661 670
63. A.C. Groo, P. Saulnier, J.C. Gimel, J. Gravier, C. Ailhas, J.P. Benoit, and F. Lagarce Fate of paclitaxel lipid nanocapsules in intestinal mucus in view of their oral delivery Int. J. Nanomed. 8 2013 4291 4302
64. J. Gualbert, P. Shahgaldian, and A.W. Coleman Interactions of amphiphilic calixarene-based, arene-based solid lipid nanoparticles with bovine serum albumin Int. J. Pharm. 257 2003 69 73
65. J. Guo, T. Wu, Q. Ping, Y. Chen, J. Shen, and G. Jiang Solubilization and pharmacokinetic behaviors of sodium cholate/lecithin-mixed micelles containing cyclosporine A Drug Deliv. 12 2005 35 39
66. F. Hajos, B. Stark, S. Hensler, R. Prassl, and W. Mosgoeller Inhalable liposomal formulation for vasoactive intestinal peptide Int. J. Pharm. 357 2008 286 294
67. T. Handa, H. Saito, and K. Miyajima Phospholipid monolayers at the triolein-saline interface: production of microemulsion particles and conversion of monolayers to bilayers Biochemistry 29 1990 2884 2890
68. C.A. Haynes, and W. Norde Globular proteins at solid/liquid interfaces Colloids Surf. B Biointerfaces 2 1994 517 566
69. J. He, K. Abdelraouf, K.R. Ledesma, D.S.-L. Chow, and V.H. Tam Pharmacokinetics and efficacy of liposomal polymyxin B in a murine pneumonia model Int. J. Antimicrob. Agents 42 2013 559 564
70. B. Heurtault, P. Saulnier, B. Pech, J.E. Proust, and J.P. Benoit A novel phase inversion-based process for the preparation of lipid nanocarriers Pharm. Res. 19 2002 875 880
71. A.M. Hillery Drug delivery: the basics concepts Drug Deilvery and Targeting for Pharmacist and Pharmaceutical Scientists 2001 Taylor & Fisher London and New York 1 48
72. T.M. Hinton, F. Grusche, D. Acharya, R. Shukla, V. Bansal, L.J. Waddington, P. Monaghan, and B.W. Muir Bicontinuous cubic phase nanoparticle lipid chemistry affects toxicity in cultured cells Toxicol. Res. (Camb.) 3 2014 11 22
73. S. Hirsjärvi, S. Dufort, G. Bastiat, P. Saulnier, C. Passirani, J.L. Coll, and J.P. Benoît Surface modification of lipid nanocapsules with polysaccharides: from physicochemical characteristics to in vivo aspects Acta Biomater. 9 2013 6686 6693
74. S. Hirsjärvi, C. Belloche, F. Hindré, E. Garcion, and J.P. Benoit Tumour targeting of lipid nanocapsules grafted with cRGD peptides Eur. J. Pharm. Biopharm. 87 2014 152 159
75. V.J. Hruby, and P.M. Balse Conformational and topographical considerations in designing agonist peptidomimetics from peptide leads Curr. Med. Chem. 7 2000 945 970
76. F.Q. Hu, Y. Hong, and H. Yuan Preparation and characterization of solid lipid nanoparticles containing peptide Int. J. Pharm. 273 2004 29 35
77. Y.L. Hu, W. Qi, F. Han, J.Z. Shao, and J.Q. Gao Toxicity evaluation of biodegradable chitosan nanoparticles using a zebrafish embryo model Int. J. Nanomed. 6 2011 3351 3359
78. J. Hureaux, F. Lagarce, F. Gagnadoux, L. Vecellio, A. Clavreul, E. Roger, M. Kempf, J.L. Racineux, P. Diot, J.P. Benoit, and T. Urban Lipid nanocapsules: ready-to-use nanovectors for the aerosol delivery of paclitaxel Eur. J. Pharm. Biopharm. 73 2009 239 246
79. N.T. Huynh, C. Passirani, P. Saulnier, and J.P. Benoit Lipid nanocapsules: a new platform for nanomedicine Int. J. Pharm. 379 2009 201 209
80. K. Iwanaga, S. Ono, K. Narioka, K. Morimoto, M. Kakemi, S. Yamashita, M. Nango, and N. Oku Oral delivery of insulin by using surface coating liposomes Int. J. Pharm. 157 1997 73 80
81. A.K. Jain, K.B. Chalasani, R.K. Khar, F.J. Ahmed, and P.V. Diwan Muco-adhesive multivesicular liposomes as an effective carrier for transmucosal insulin delivery J. Drug Target 15 2007 417 427
82. K. Jain, P. Kesharwani, U. Gupta, and N.K. Jain Dendrimer toxicity: let's meet the challenge Int. J. Pharm. 394 2010 122 142
83. V. Jenning, K. Mäder, and S.H. Gohla Solid lipid nanoparticles (SLN) based on binary mixtures of liquid and solid lipids: a (1) H-NMR study Int. J. Pharm. 205 2000 15 21
84. V. Jenning, A.F. Thünemann, and S.H. Gohla Characterisation of a novel solid lipid nanoparticle carrier system based on binary mixtures of liquid and solid lipids Int. J. Pharm. 199 2000 167 177
85. A. Jesorka, and O. Orwar Liposomes: technologies and analytical applications Annu. Rev. Anal. Chem. 1 2008 801 832
86. M. Johnsson, Y. Lam, J. Barauskas, and F. Tiberg Aqueous phase behavior and dispersed nanoparticles of diglycerol monooleate/glycerol dioleate mixtures Langmuir 21 2005 5159 5165
87. M. Jumaa, and B.W. Müller Lipid emulsions as a novel system to reduce the hemolytic activity of lytic agents: mechanism of the protective effect Eur. J. Pharm. Sci. 9 2000 285 290
88. K.H. Chen, M. Di Sabatino, B. Albertini, N. Passerini, and V.L. Kett The effect of polymer coatings on physicochemical properties of spray-dried liposomes for nasal delivery of BSA Eur. J. Pharm. Sci. 50 2013 312 322
89. O. Kayser, R.H. Müller, and S.A. Wissing Solid lipid nanoparticles for parenteral drug delivery Adv. Drug Deliv. Rev. 56 2004 1257 1272
90. A.A. Khan, J. Mudassir, N. Mohtar, and Y. Darwis Advanced drug delivery to the lymphatic system: lipid-based nanoformulations Int. J. Nanomed. 2013
91. K. Khosravi-Darani, A. Pardakhty, H. Honarpisheh, V.S.N.M. Rao, and M.R. Mozafari The role of high-resolution imaging in the evaluation of nanosystems for bioactive encapsulation and targeted nanotherapy Micron 38 2007 804 818
92. S.T. Kim, D.J. Jang, J.H. Kim, J.Y. Park, J.S. Lim, S.Y. Lee, K.M. Lee, S.J. Lim, and C.K. Kim Topical administration of cyclosporin A in a solid lipid nanoparticle formulation Pharmazie 64 2009 510 514
93. M. Kokkona, P. Kallinteri, D. Fatouros, and S.G. Antimisiaris Stability of SUV liposomes in the presence of cholate salts and pancreatic lipases: effect of lipid composition Eur. J. Pharm. Sci. 9 2000 245 252
94. K.S. Konduri, S. Nandedkar, N. Düzgünes, V. Suzara, J. Artwohl, R. Bunte, and P.R.J. Gangadharam Efficacy of liposomal budesonide in experimental asthma J. Allergy Clin. Immunol. 111 2003 321 327
95. M. Kong, and H.J. Park Stability investigation of hyaluronic acid based nanoemulsion and its potential as transdermal carrier Carbohydr. Polym. 83 2011 1303 1310
96. O.M. Koo, I. Rubinstein, and H. Onyuksel Camptothecin in sterically stabilized phospholipid micelles: a novel nanomedicine Nanomed. Nanotechnol. Biol. Med. 1 2005 77 84
97. O.M.Y. Koo, I. Rubinstein, and H. Önyüksel Actively targeted low-dose camptothecin as a safe long-acting, disease-modifying nanomedicine for rheumatoid arthritis Pharm. Res. 28 2011 776 787
98. K. Kostarelos The long and short of carbon nanotube toxicity Nat. Biotechnol. 26 2008 774 776
99. A. Krishnadas, H. Onyüksel, and I. Rubinstein Interactions of VIP: secretin and PACAP(1-38) with phospholipids: a biological paradox revisited Curr. Pharm. Des. 9 2003 1005 1012
100. C.V. Kulkarni, W. Wachter, G. Iglesias-Salto, S. Engelskirchen, and S. Ahualli Monoolein: a magic lipid? Phys. Chem. Chem. Phys. 13 2011 3004 3021
101. M. Kumar, A. Misra, A.K. Babbar, A.K. Mishra, P. Mishra, and K. Pathak Intranasal nanoemulsion based brain targeting drug delivery system of risperidone Int. J. Pharm. 358 2008 285 291
102. F. Kuo, B. Subramanian, T. Kotyla, T.A. Wilson, S. Yoganathan, and R.J. Nicolosi Nanoemulsions of an anti-oxidant synergy formulation containing gamma tocopherol have enhanced bioavailability and anti-inflammatory properties Int. J. Pharm. 363 2008 206 213
103. A. Kuzmis, S.B. Lim, E. Desai, E. Jeon, B.S. Lee, I. Rubinstein, and H. Önyüksel Micellar nanomedicine of human neuropeptide Y. Nanomedicine nanotechnology Biol. Med. 7 2011 464 471
104. J. Lai, Y. Lu, Z. Yin, F. Hu, and W. Wu Pharmacokinetics and enhanced oral bioavailability in beagle dogs of cyclosporine A encapsulated in glyceryl monooleate/poloxamer 407 cubic nanoparticles Int. J. Nanomed. 5 2010 13 23
105. A. Lamprecht, J.L. Saumet, J. Roux, and J.P. Benoit Lipid nanocarriers as drug delivery system for ibuprofen in pain treatment Int. J. Pharm. 278 2004 407 414
106. S.D. Larson, L.N. Jackson, L.A. Chen, P.G. Rychahou, and B.M. Evers Effectiveness of siRNA uptake in target tissues by various delivery methods Surgery 142 2007 262 269
107. K. Larsson, and F. Tiberg Periodic minimal surface structures in bicontinuous lipid-water phases and nanoparticles Curr. Opin. Colloid Interface Sci. 9 2005 365 369
108. D.D. Lasic, J.J. Vallner, and P.K. Working Sterically stabilized liposomes in cancer therapy and gene delivery Curr. Opin. Mol. Ther. 1 1999 177 185
109. D.D. Lasic Novel application of liposomes Trends Biotechnol. 16 1998 307 321
110. X. Li, J. Qi, Y. Xie, X. Zhang, S. Hu, Y. Xu, Y. Lu, and W. Wu Nanoemulsions coated with alginate/chitosan as oral insulin delivery systems: preparation, characterization, and hypoglycemic effect in rats Int. J. Nanomed. 8 2013 23 32
111. S.B. Lim, I. Rubinstein, and H. Önyüksel Freeze drying of peptide drugs self-associated with long-circulating, biocompatible and biodegradable sterically stabilized phospholipid nanomicelles Int. J. Pharm. 356 2008 345 350
112. S.B. Lim, I. Rubinstein, R.T. Sadikot, J.E. Artwohl, and H. Önyüksel A novel peptide nanomedicine against acute lung injury: GLP-1 in phospholipid micelles Pharm. Res. 28 2011 662 672
113. S.B. Lim, A. Banerjee, and H. Önyüksel Improvement of drug safety by the use of lipid-based nanocarriers J. Control. Release 163 2012 34 45
114. W. Liu, D. Sun, C. Li, Q. Liu, and J. Xu Formation and stability of paraffin oil-in-water nano-emulsions prepared by the emulsion inversion point method Interface 303 2006 557 563
115. J. Liu, T. Gong, C. Wang, Z. Zhong, and Z. Zhang Solid lipid nanoparticles loaded with insulin by sodium cholate-phosphatidylcholine-based mixed micelles: preparation and characterization Int. J. Pharm. 340 2007 153 162
116. J. Liu, W. Hu, H. Chen, Q. Ni, H. Xu, and X. Yang Isotretinoin-loaded solid lipid nanoparticles with skin targeting for topical delivery Int. J. Pharm. 328 2007 191 195
117. L.B. Lopes, D.A. Ferreira, D. De Paula, M.T.J. Garcia, J.A. Thomazini, M.C.A. Fantini, and M.V.L.B. Bentley Reverse hexagonal phase nanodispersion of monoolein and oleic acid for topical delivery of peptides: in vitro and in vivo skin penetration of cyclosporin A Pharm. Res. 23 2006 1332 1342
118. L.B. Lopes, F.F.F. Speretta, and M.V.L.B. Bentley Enhancement of skin penetration of vitamin K using monoolein-based liquid crystalline systems Eur. J. Pharm. Sci. 32 2007 209 215
119. G. Lopez-Berestein, V. Fainstein, R. Hopfer, K. Mehta, M.P. Sullivan, M. Keating, M.G. Rosenblum, R. Mehta, M. Luna, E.M. Hersh, J. Reuben, R.L. Juliano, and G.P. Bodey Liposomal amphotericin B for the treatment of systemic fungal infections in patients with cancer: a preliminary study J. Infect. Dis. 151 1985 704 710
120. Lucks, S., Muller, R., 1993. Medication Vehicles Made of Solid Lipid Particles (Solid Lipid Nanospheres-SLN) CA2119253 A1.
121. K. Mäder, and W. Mehnert Solid lipid nanoparticles: production: characterization and applications Adv. Drug Deliv. Rev. 47 2001 165 196
122. R.H. Müller, and C.M. Keck Drug delivery to the brain -realization by novel drug carriers J. Nanosci. Nanotechnol. 4 2004 471 483
123. R.H. Müller, D. Rühl, and S.A. Runge Biodegradation of solid lipid nanoparticles as a function of lipase incubation time Int. J. Pharm. 144 1996 115 121
124. R.H. Müller, K. Mäder, and S. Gohla Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art Eur. J. Pharm. Biopharm. 50 2000 161 177
125. R.H. Müller, M. Radtke, and S.A. Wissing Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations Adv. Drug Deliv. Rev. 54 2002 S131 S155
126. R.H. Müller, M. Radtke, and S.A. Wissing Nanostructured lipid matrices for improved microencapsulation of drugs Int. J. Pharm. 242 2002 121 128
127. ®) versus drug nanocrystals Int. J. Pharm. 317 2006 82 89
128. T.G. Mason, J.N. Wilking, K. Meleson, C.B. Chang, and S.M. Graves Nanoemulsions: formation structure, and physical properties J. Phys. Condens. Matter 18 2006 R635 R666
129. E.G. Mayhew, M.H. Goldrosen, J. Vaage, and Y.M. Rustum Effects of liposome-entrapped doxorubicin on liver metastases of mouse colon carcinomas 26 and 38 J. Natl. Cancer Inst. 78 1987 707 713
130. W. Mehnert Solid lipid nanoparticles production: characterization and applications Adv. Drug Deliv. Rev. 47 2001 165 196
131. K. Messaoudi, P. Saulnier, K. Boesen, J.P. Benoit, and F. Lagarce Anti-epidermal growth factor receptor siRNA carried by chitosan-transacylated lipid nanocapsules increases sensitivity of glioblastoma cells to temozolomide Int. J. Nanomed. 9 2014 1479 1490
132. S. Milak, and A. Zimmer Glycerol monooleate liquid crystalline phases used in drug delivery systems Int. J. Pharm. 478 2015 569 587
133. V.J. Mohanraj, T.J. Barnes, and C.A. Prestidge Silica nanoparticle coated liposomes: a new type of hybrid nanocapsule for proteins Int. J. Pharm. 392 2010 285 293
134. M. Morille, T. Montier, P. Legras, N. Carmoy, P. Brodin, B. Pitard, J.P. Benoît, and C. Passirani Long-circulating DNA lipid nanocapsules as new vector for passive tumor targeting Biomaterials 31 2010 321 329
135. M.R. Mozafari, C. Johnson, S. Hatziantoniou, and C. Demetzos Nanoliposomes and their applications in food nanotechnology J. Liposome Res. 18 2008 309 327
136. M. Muchow, P. Maincent, and R.H. Muller Lipid nanoparticles with a solid matrix (SLN, NLC, LDC) for oral drug delivery Drug Dev. Ind. Pharm. 34 2008 1394 1405
137. S. Mukherjee, S. Ray, and R.S. Thakur Solid lipid nanoparticles: a modern formulation approach in drug delivery system Indian J. Pharm. Sci. 71 2009 349 358
138. X. Mulet, D.F. Kennedy, C.E. Conn, A. Hawley, and C.J. Drummond High throughput preparation and characterisation of amphiphilic nanostructured nanoparticulate drug delivery vehicles Int. J. Pharm. 395 2010 290 297
139. X. Mulet, B.J. Boyd, and C.J. Drummond Advances in drug delivery and medical imaging using colloidal lyotropic liquid crystalline dispersions J. Colloid Interface Sci. 393 2013 1 20
140. F. Muller, A. Salonen, and O. Glatter Phase behavior of phytantriol/water bicontinuous cubic Pn3m cubosomes stabilized by laponite disc-like particles J. Colloid Interface Sci. 342 2010 392 398
141. F. Muller, A. Salonen, and O. Glatter Monoglyceride-based cubosomes stabilized by Laponite: separating the effects of stabilizer, pH and temperature Colloids Surf. A Physicochem. Eng. Aspects 358 2010 50 56
142. S. Murakami, T. Ono, S. Sakai, H. Ijima, and K. Kawakami Effect of diglucosamine on the entrapment of protein into liposomes J. Liposome Res. 16 2006 103 112
143. S. Murgia, A.M. Falchi, M. Mano, S. Lampis, R. Angius, A.M. Carnerup, J. Schmidt, G. Diaz, M. Giacca, Y. Talmon, and M. Monduzzi Nanoparticles from lipid-based liquid crystals: emulsifier influence on morphology and cytotoxicity J. Phys. Chem. B 114 2010 3518 3525
144. T.-H. Nguyen, T. Hanley, C.J.H. Porter, I. Larson, and B.J. Boyd Phytantriol and glyceryl monooleate cubic liquid crystalline phases as sustained-release oral drug delivery systems for poorly water-soluble drugs II In-vivo evaluation J. Pharm. Pharmacol. 62 2010 856 865
145. T.H. Nguyen, T. Hanley, C.J.H. Porter, and B.J. Boyd Nanostructured liquid crystalline particles provide long duration sustained-release effect for a poorly water soluble drug after oral administration J. Control. Release 153 2011 180 186
146. J.W. Nichols Phospholipids Handbook G. Cevc, 1993 Marcel Dekker New York
147. M. Ohnishi, and H. Sagitani The effect of nonionic surfactant structure on hemolysis J. Am. Oil Chem. Soc. 70 1993 679 684
148. C. Olbrich Entrapment efficiency and biodegradation of cyclosporine loaded solid lipid nanoparticles for peroral administration 3rd World Meeting APV/APGI 2000
149. A. Omri, Z.E. Suntres, and P.N. Shek Enhanced activity of liposomal polymyxin B against Pseudomonas aeruginosa in a rat model of lung infection Biochem. Pharmacol. 64 2002 1407 1413
150. C. Oussoren, and G. Storm Liposomes to target the lymphatics by subcutaneous administration Adv. Drug Deliv. Rev. 50 2001 143 156
151. C. Pérez, I.J. Castellanos, H.R. Costantino, W. Al-Azzam, and K. Griebenow Recent trends in stabilizing protein structure upon encapsulation and release from bioerodible polymers J. Pharm. Pharmacol. 54 2002 301 313
152. R. Pandey, and G.K. Khuller Solid lipid particle-based inhalable sustained drug delivery system against experimental tuberculosis Tuberculosis 85 2005 227 234
153. S.F. Pantze, J. Parmentier, G. Holfhaus, and G. Fricker Matrix liposomes: a solid liposomal formulation for oral administration Eur. J. Lipid Sci. Technol. 116 2014 1145 1154
154. Parmar, H., 2004. Therapeutic Peptides in Europe: Finding the Opportunities November 2004.
155. M. Partearroyo, and H. Ostolaza Surfactant-induced cell toxicity and cell lysis: a study using B16 melanoma cells Biochem. Pharmacol. 40 1990 1323 1328
156. A.S. Pattani, S.D. Mandawgade, and V.B. Patravale Development and comparative anti-Microbial evaluation of lipid nanoparticles and nanoemulsion of polymyxin B J. Nanosci. Nanotechnol. 6 2006 2986 2990
157. M.C. Pedroso de Lima, S. Simões, P. Pires, H. Faneca, and N. Düzgüneş Cationic lipid-DNA complexes in gene delivery: from biophysics to biological applications Adv. Drug Deliv. Rev. 47 2001 277 294
158. Penkler, L., Müller, J., Helmut, R., Runge, S., Anton Ravelli, V., 2003. Pharmaceutical cyclosporin formulation with improved biopharmaceutical properties, improved physical quality and greater stability, and method for producing said formulation US6551619 B1.
159. C. Pichereau, and C. Allary Therapeutic peptides under the spotlight Eur. Biopharm. Rev. 2005 88 93
160. C. Prego, D. Torres, E. Fernandez-Megia, R. Novoa-Carballal, E. Quiñoá, and M.J. Alonso Chitosan-PEG nanocapsules as new carriers for oral peptide delivery: effect of chitosan pegylation degree J. Control. Release 111 2006 299 308
161. M. Radtke, and R. Müller Nanostructured lipid drug carriers New Drugs 2 2001 48 51
162. A. Ramadan, F. Lagarce, A. Tessier-Marteau, O. Thomas, P. Legras, L. Macchi, P. Saulnier, and J.P. Benoit Oral fondaparinux: use of lipid nanocapsules as nanocarriers and in vivo pharmacokinetic study Int. J. Nanomed. 6 2011 2941 2951
163. T. Rattanapak, K. Young, T. Rades, and S. Hook Comparative study of liposomes, transfersomes, ethosomes and cubosomes for transcutaneous immunisation: characterisation and in vitro skin penetration J. Pharm. Pharmacol. 64 2012 1560 1569
164. M. Rawat, D. Singh, S. Saraf, and S. SARAF Lipid carriers: a versatile delivery vehicle for proteins and peptides Yakugaku Zasshi 128 2008 269 280
165. H. Reithmeier, J. Herrmann, and A. Göpferich Lipid microparticles as a parenteral controlled release device for peptides J. Control. Release 73 2001 339 350
166. S.B. Rizwan, B.J. Boyd, T. Rades, and S. Hook Bicontinuous cubic liquid crystals as sustained delivery systems for peptides and proteins Expert Opin. Drug Deliv. 7 2010 1133 1144
167. S.B. Rizwan, D. Assmus, A. Boehnke, T. Hanley, B.J. Boyd, T. Rades, and S. Hook Preparation of phytantriol cubosomes by solvent precursor dilution for the delivery of protein vaccines Eur. J. Pharm. Biopharm. 79 2011 15 22
168. S.B. Rizwan, W.T. McBurney, K. Young, T. Hanley, B.J. Boyd, T. Rades, and S. Hook Cubosomes containing the adjuvants imiquimod and monophosphoryl lipid A stimulate robust cellular and humoral immune responses J. Control. Release 165 2013 16 21
169. E. Roger, F. Lagarce, and J.P. Benoit The gastrointestinal stability of lipid nanocapsules Int. J. Pharm. 379 2009 260 265
170. E. Roger, F. Lagarce, and J.P. Benoit Development and characterization of a novel lipid nanocapsule formulation of Sn38 for oral administration Eur. J. Pharm. Biopharm. 79 2011 181 188
171. R. Rowe, J.P. Sheskey, and E. Quinn Handbook of Pharmaceutical Excipients 2009 Pharmaceutical Press; American Pharmacists Association London, Chicago, Washington, DC
172. T. Ruysschaert, M. Germain, J.F.P.D.S. Gomes, D. Fournier, G.B. Sukhorukov, W. Meier, and M. Winterhalter Liposome-based nanocapsules IEEE Trans. Nanobiosci. 3 2004 49 55
173. B. Saliou, O. Thomas, N. Lautram, A. Clavreul, J. Hureaux, T. Urban, J.P. Benoit, and F. Lagarce Development and in vitro evaluation of a novel lipid nanocapsule formulation of etoposide Eur. J. Pharm. Sci. 50 2013 172 180
174. S. Salmaso, S. Bersani, N. Elvassore, A. Bertucco, and P. Caliceti Biopharmaceutical characterisation of insulin and recombinant human growth hormone loaded lipid submicron particles produced by supercritical gas micro-atomisation Int. J. Pharm. 379 2009 51 58
175. S. Salmaso, N. Elvassore, A. Bertucco, and P. Caliceti Production of solid lipid submicron particles for protein delivery using a novel supercritical gas-assisted melting atomization process J. Pharm. Sci. 98 2009 640 650
176. A. Samad, Y. Sultana, and M. Aqil Liposomal drug delivery systems: an update review Curr. Drug Deliv. 4 2007 297 305
177. D.K. Sarker Engineering of nanoemulsions for drug delivery Curr. Drug Deliv. 2 2005 297 310
178. S. Selvamuthukumar, and R. Velmurugan Nanostructured lipid carriers: a potential drug carrier for cancer chemotherapy Lipids Health Dis. 11 2012 159
179. S.C. Semple, A. Chonn, and P.R. Cullis Interactions of liposomes and lipid-based carrier systems with blood proteins: relation to clearance behaviour in vivo Adv. Drug Deliv. Rev. 32 1998 3 17
180. V. Sethi, H. Onyüksel, and I. Rubinstein Liposomal vasoactive intestinal peptide Methods Enzymol. 391 2005 377 395
181. V. Sethi, I. Rubinstein, A. Kuzmis, H. Kastrissios, J. Artwohl, and H. Onyuksel Novel biocompatible, and disease modifying VIP nanomedicine for rheumatoid arthritis Mol. Pharm. 10 2013 728 738
182. J.C. Shah, Y. Sadhale, and D.M. Chilukuri Cubic phase gels as drug delivery systems Adv. Drug Deliv. Rev. 47 2001 229 250
183. G. Sharma, K. Wilson, C.F. van der Walle, N. Sattar, J.R. Petrie, and M.N.V. Ravi Kumar Microemulsions for oral delivery of insulin: design, development and evaluation in streptozotocin induced diabetic rats Eur. J. Pharm. Biopharm. 76 2010 159 169
184. J. Shen, Y. Deng, X. Jin, Q. Ping, Z. Su, and L. Li Thiolated nanostructured lipid carriers as a potential ocular drug delivery system for cyclosporine A: improving in vivo ocular distribution Int. J. Pharm. 402 2010 248 253
185. S.J.H. Soenen, and M. De Cuyper Assessing iron oxide nanoparticle toxicity in vitro: current status and future prospects Nanomed. (Lond.) 5 2010 1261 1275
186. S. Sood, K. Jain, and K. Gowthamarajan Optimization of curcumin nanoemulsion for intranasal delivery using design of experiment and its toxicity assessment Colloids Surf. B Biointerfaces 113 2014 330 337
187. E.B. Souto, S.A. Wissing, C.M. Barbosa, and R.H. Müller Development of a controlled release formulation based on SLN and NLC for topical clotrimazole delivery Int. J. Pharm. 278 2004 71 77
188. ®) Int. J. Pharm. 295 2005 261 268
189. P. Spicer Cubosome ProcessingIndustrial nanoparticle technology development Chem. Eng. Res. Des. 83 2005 1283 1286
190. B. Stark, P. Debbage, F. Andreae, W. Mosgoeller, and R. Prassl Association of vasoactive intestinal peptide with polymer-grafted liposomes: structural aspects for pulmonary delivery Biochim. Biophys. Acta 1768 2007 705 714
191. W.W. Sulkowski, D. Pentak, W. Korus, and A. Sulkowska Effect of temperature on liposome structures studied using EPR spectroscopy Spectroscopy 19 2005 37 42
192. N.K. Swarnakar, V. Jain, V. Dubey, D. Mishra, and N.K. Jain Enhanced oromucosal delivery of progesterone via hexosomes Pharm. Res. 24 2007 2223 2230
193. P.T. Spicer, K.L. Hayden, M.L. Lynch, A. Ofori-Boateng, and J.L. Burns Novel process for producing cubic liquid crystalline nanoparticles (cubosomes) Langmuir 17 2001 5748 5756
194. T. Tadros, P. Izquierdo, J. Esquena, and C. Solans Formation and stability of nano-emulsions Adv. Colloid Interface Sci. 108-109 2004 303 318
195. H. Takeuchi, Y. Matsui, H. Yamamoto, and Y. Kawashima Mucoadhesive properties of carbopol or chitosan-coated liposomes and their effectiveness in the oral administration of calcitonin to rats J. Control. Release 86 2003 235 242
196. H. Takeuchi, Y. Matsui, H. Sugihara, H. Yamamoto, and Y. Kawashima Effectiveness of submicron-sized: chitosan-coated liposomes in oral administration of peptide drugs Int. J. Pharm. 303 2005 160 170
197. D. Tamayo-Esquivel, A. Ganem-Quintanar, A. Martinez, M. Navarrete-Rodriguez, S. Rodríguez-Romo, and D. Quintanar-Guerrero Evaluation of the enhanced oral effect of omapatrilat-monolein nanoparticles prepared by the emulsification-diffusion method J. Nanosci. Nanotechnol. 6 2006 3134 3138
198. J. Thongborisute, H. Takeuchi, H. Yamamoto, and Y. Kawashima Properties of liposomes coated with hydrophobically modified chitosan in oral liposomal drug delivery Pharmazie 61 2006 106 111
199. N. Thirawong, J. Thongborisute, H. Takeuchi, and P. Sriamornsak Improved intestinal absorption of calcitonin by mucoadhesive delivery of novel pectin-liposome nanocomplexes J. Control. Release 125 2008 236 245
200. V.P. Torchilin Recent advances with liposomes as pharmaceutical carriers Nat. Rev. Drug Discov. 4 2005 145 160
201. V.P. Torchilin Micellar nanocarriers: pharmaceutical perspectives Pharm. Res. 24 2007 1 16
202. E. Ugazio, R. Cavalli, and M.R. Gasco Incorporation of cyclosporin A in solid lipid nanoparticles (SLN) Int. J. Pharm. 241 2002 341 344
203. S. Vemuri, and C.T. Rhodes Preparation and characterization of liposomes as therapeutic delivery systems: a review Pharm. Acta Helv. 70 1995 95 111
204. A. Vonarbourg, C. Passirani, P. Saulnier, and J.P. Benoit Parameters influencing the stealthiness of colloidal drug delivery systems Biomaterials 27 2006 4356 4373
205. A. Vonarbourg, C. Passirani, L. Desigaux, E. Allard, P. Saulnier, O. Lambert, J.P. Benoit, and B. Pitard The encapsulation of DNA molecules within biomimetic lipid nanocapsules Biomaterials 30 2009 3197 3204
206. S. Vrignaud, N. Anton, P. Gayet, J.P. Benoit, and P. Saulnier Reverse micelle-loaded lipid nanocarriers: a novel drug delivery system for the sustained release of doxorubicin hydrochloride Eur. J. Pharm. Biopharm. 79 2011 197 204
207. S. Vrignaud, J. Hureaux, S. Wack, J.P. Benoit, and P. Saulnier Design: optimization and in vitro evaluation of reverse micelle-loaded lipid nanocarriers containing erlotinib hydrochloride Int. J. Pharm. 436 2012 194 200
208. S.P. Vyas, M.E. Kannan, S. Jain, V. Mishra, and P. Singh Design of liposomal aerosols for improved delivery of rifampicin to alveolar macrophages Int. J. Pharm. 269 2004 37 49
209. M. Wadsäter, J. Barauskas, T. Nylander, and F. Tiberg Formation of highly structured cubic micellar lipid nanoparticles of soy phosphatidylcholine and glycerol dioleate and their degradation by triacylglycerol lipase ACS Appl. Mater. Interfaces 6 2014 7063 7069
210. M. Wadsäter, J. Barauskas, S. Rogers, M.W. Skoda, R.K. Thomas, F. Tiberg, and T. Nylander Structural effects of the dispersing agent polysorbate 80 on liquid crystalline nanoparticles of soy phosphatidylcholine and glycerol dioleate Soft Matter 11 2015 1140 1150
211. A. Wagner, and K. Vorauer-Uhl Liposome technology for industrial purposes J. Drug Deliv. 2011 2011 591325
212. Y. Wang, R. Wang, X. Lu, W. Lu, C. Zhang, and W. Liang Pegylated phospholipids-based self-assembly with water-soluble drugs Pharm. Res. 27 2010 361 370
213. M. Weyland, A. Griveau, J. Bejaud, J.P. Benoit, P. Coursaget, and E. Garcion Lipid nanocapsule functionalization by lipopeptides derived from human papillomavirus type-16 capsid for nucleic acid delivery into cancer cells Int. J. Pharm. 454 2013 756 764
214. P.K. Working, and A.D. Dayan Pharmacological-toxicological expert report: CAELYX. (Stealth liposomal doxorubicin HCl) Hum. Exp. Toxicol. 15 1996 751 785
215. M. Werle, and H. Takeuchi Chitosan-aprotinin coated liposomes for oral peptide delivery: development, characterisation and in vivo evaluation Int. J. Pharm. 370 2009 26 32
216. H. Wu, C. Ramachandran, A.U. Bielinska, K. Kingzett, R. Sun, N.D. Weiner, and B.J. Roessler Topical transfection using plasmid DNA in a water-in-oil nanoemulsion Int. J. Pharm. 221 2001 23 34
217. Z. Yang, Y. Tan, M. Chen, L. Dian, Z. Shan, X. Peng, and C. Wu Development of amphotericin B-loaded cubosomes through the SolEmuls technology for enhancing the oral bioavailability AAPS PharmSciTech 13 2012 1483 1491
218. Q. Ye, J. Asherman, M. Stevenson, E. Brownson, and N.V. Katre DepoFoam(TM) technology: a vehicle for controlled delivery of protein and peptide drugs J. Control. Release 64 2000 155 166
219. H. Yuan, J. Miao, Y.Z. Du, J. You, F.Q. Hu, and S. Zeng Cellular uptake of solid lipid nanoparticles and cytotoxicity of encapsulated paclitaxel in A549 cancer cells Int. J. Pharm. 348 2008 137 145
220. Y. Yang, A. Corona, B. Schubert, R. Reeder, and M.A. Henson The effect of oil type on the aggregation stability of nanostructured lipid carriers J. Colloid Interface Sci. 418 2014 261 272
221. Z. Yang, M. Chen, M. Yang, J. Chen, W. Fang, and P. Xu Evaluating the potential of cubosomal nanoparticles for oral delivery of amphotericin B in treating fungal infection Int. J. Nanomed. 9 2014 327 336
222. J. Zhai, L. Waddington, T.J. Wooster, M.I. Aguilar, and B.J. Boyd Revisiting β-casein as a stabilizer for lipid liquid crystalline nanostructured particles Langmuir 27 2011 14757 14766
223. Q. Zhang, G. Yie, Y. Li, Q. Yang, and T. Nagai Studies on the cyclosporin A loaded stearic acid nanoparticles Int. J. Pharm. 200 2000 153 159
224. N. Zhang, Q.N. Ping, G.H. Huang, and W.F. Xu Investigation of lectin-modified insulin liposomes as carriers for oral administration Int. J. Pharm 294 2005 247 259
225. N. Zhang, Q. Ping, G. Huang, W. Xu, Y. Cheng, and X. Han Lectin-modified solid lipid nanoparticles as carriers for oral administration of insulin Int. J. Pharm. 327 2006 153 159
226. N.J. Zuidam, H.K. Gouw, Y. Barenholz, and D.J. Crommelin Physical (in) stability of liposomes upon chemical hydrolysis: the role of lysophospholipids and fatty acids Biochim. Biophys. Acta 1240 1995 101 110